The GDELT Project

  • The GDELT Project Blog
  • Website

What If We Treated AI Bias Testing Like Clinical Drug Trials?

 January 27, 2019

Centralizing and systematizing our approach to evaluating AI bias would force companies to disclose their target demographics and offer the public an independent trustworthy evaluation of how well products serve those demographics, with results that can be directly compared across the marketplace.

Read The Full Article.

Post navigation

← Does 'Name And Shame' Really Work For Fighting AI Bias Or Is It All Economics?
416 Forbes Columns And Counting →

Archives

The Official GDELT Project Blog